Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study. (2022)

First Author: Zhao Y

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fneur.2022.940118

PubMed Identifier: 36119674

Publication URI: http://europepmc.org/abstract/MED/36119674

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in neurology

ISSN: 1664-2295